Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,350.90
-19.10 (-1.39%)
Aug 21, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 165.81 billion as of August 21, 2026. Its market cap has increased by 39.90% in one year.
Market Cap
165.81B
Enterprise Value
158.55B
Revenue
25.90B
Ranking
n/a
PE Ratio
27.55
Stock Price
1,350.90
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 165.81B, an increase of 80.79%. That is a compound annual growth rate of 12.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 165.81B | 47.45% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 358.51B |
| Wockhardt | 296.71B |
| Piramal Pharma | 278.23B |
| Eris Lifesciences | 186.83B |
| Cohance Lifesciences | 170.95B |
| Alembic Pharmaceuticals | 160.69B |
| NATCO Pharma | 158.84B |
| Sudeep Pharma | 130.61B |